Supranuclear palsy, progressive, 1
MONDO:0010997Classical progressive supranuclear palsy, also known as Richardson's syndrome, is the most common clinical variant of progressive supranuclear palsy (PSP), a rare late-onset neurodegenerative disease characterized by postural instability, progressive rigidity, supranuclear gaze palsy and mild dementia.
Also known as: Steele-Richardson-Olszewski disease, Steele-Richardson-Olszewski syndrome, PSP, Richardson syndrome, classic PSP syndrome, classic progressive supranuclear palsy syndrome, supranuclear palsy, progressive, supranuclear palsy, progressive, 1
17 clinical trials for this condition and its sub-types, 5 tagged with Supranuclear palsy, progressive, 1 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New hope for rare brain disease: phase 3 trial of NIO752 underway
Disease control Recruiting nowThis study tests an experimental drug called NIO752 in 300 people with progressive supranuclear palsy (PSP), a rare brain disorder that affects movement and balance. Participants are randomly assigned to receive either the drug or a placebo. After the main study, everyone can rec…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
AI hunts for early clues to Parkinson's and Alzheimer's progression
Knowledge-focused Recruiting nowThis study follows 600 people with neurodegenerative diseases such as Parkinson's, Alzheimer's, and related conditions over 1 to 10 years. Researchers collect data from routine clinical exams, brain imaging, movement analysis, and blood tests. They use statistical tools and artif…
Sponsor: Casa di Cura San Raffaele Cassino • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC